Nichi-In* Centre for Regenerative Medicine (NCRM)
is an institute carrying out research, training (both scientists and physicians) clinical applications-protocol development in regenerative medicine based on cell therapeutics, with emphasis on stem cells, Progenitor cells, precursor cells and autologous cells with regenerative capability and to take them to en mass clinical application, while maintaining the highest ethical and scientific values of international standards
NCRM`s initiatives:
CESBANK (Worlds First Corneal Endothelial Stem Cell Bank)
Nichi-In Galaxy of Regenerative Medicine (NGRM)
Cell therapy for male urethral stricture- BEES-HAUS & BHES-HAUS

Nichi-In Bio Sciences Private Limited
is an Indo–Japanese joint venture dedicated to advancing regenerative medicine and allied biomedical research. Its R & D arm, the Nichi-In Centre for Regenerative Medicine (NCRM), has been actively engaged in research and innovation in regenerative medicine and related fields since 2006, contributing to translational science and global collaborations. In strategic alliance with Medinippon Healthcare Pvt. Ltd., India,NCRM has expanded its international footprint with laboratory operations in Mauritius in collaboration with SoulSynergy, Mauritiusand global headquarters, the GN Corporation Co Ltd, Japan, which provides strategic direction and international coordination. Medical device imports in India are handled by Medinippon Healthcare Pvt. Ltd.,ensuring compliance and streamlined distribution. Through strong Indo–Japanese collaboration, Nichi-In Biosciences continues to work toward innovation, quality, and global impact in regenerative medicine and healthcare technologies.